Mylisa Parette

Title: Mylisa Parette: Innovator in Therapeutic Nanoparticles

Introduction

Mylisa Parette is a notable inventor based in Bellefonte, PA (US). She has made significant contributions to the field of therapeutic nanoparticles, particularly in the development of innovative solutions for disease treatment. Her work focuses on the incorporation of siRNA into calcium phosphate nanoparticles, which has the potential to revolutionize targeted therapies.

Latest Patents

Mylisa holds a patent for "Therapeutic calcium phosphate nanoparticle incorporating siRNA useful in treating disease." This patent describes the formation of stable, non-toxic calcium phosphate nanoparticles that incorporate one or more oligonucleotides, specifically siRNA nucleotides. The nanoparticles are designed to dissociate, leaving only naturally occurring residual materials, calcium and phosphate, along with the siRNA. This innovative approach allows for the simultaneous blocking or knockdown of multiple targeted proteins, enhancing the efficacy of treatments.

Career Highlights

Throughout her career, Mylisa has demonstrated a commitment to advancing medical technology through her research and inventions. Her work has garnered attention for its potential applications in various therapeutic areas, showcasing her expertise in the field of nanomedicine.

Collaborations

Mylisa collaborates with talented individuals such as Danielle Asquino and Kari Eyer, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mylisa Parette is a pioneering inventor whose work in therapeutic nanoparticles holds great promise for the future of medicine. Her contributions to the field exemplify the impact of innovative thinking in addressing complex health challenges.